Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity - Editorial comment

被引:42
|
作者
Chancellor, MB [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15261 USA
来源
JOURNAL OF UROLOGY | 2004年 / 171卷 / 02期
关键词
Bladder; neurogenic; Botulinum toxins; Drug resistance;
D O I
10.1097/01.ju.0000108407.53880.6a
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:804 / 805
页数:2
相关论文
共 50 条
  • [31] Re: Failure of Botulinum Toxin Injection for Neurogenic Detrusor Overactivity: Switch of Toxin Versus Second Injection of the Same Toxin
    Irkilata, Lokman
    JOURNAL OF UROLOGICAL SURGERY, 2015, 2 (04): : 204 - 204
  • [32] Botulinum Toxin A Intradetrusor Injection for Treating Neurogenic Detrusor Overactivity, A Single Centre Experience
    Mosli, Hisham A.
    Awad, Mohannad A.
    Rezk, Mamdouh M.
    Alsabban, Abdulrahman E.
    Tayib, Abdulmalik M. S.
    Abdulwahab, Mohammed H.
    Assiri, Moayad A.
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2014, 6 (03) : 162 - 166
  • [33] Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury
    Patki, Prasaid S.
    Hamid, Rizwan
    Arumugam, Kirupakar
    Shah, P. Julian R.
    Craggs, Mike
    BJU INTERNATIONAL, 2006, 98 (01) : 77 - 82
  • [34] Editorial Comment to Botulinum toxin A injection for the treatment of neurogenic detrusor overactivity secondary to spinal cord injury: Multi-institutional experience in Japan
    Hillelsohn, Joel
    Matthews, Gerald
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (03) : 310 - 310
  • [35] Comment on: "Cost comparison of intra-detrusor injection of botulinum toxin versus augmentation cystoplasty for refractory Neurogenic Detrusor Overactivity in Children"
    Olsen, L. Henning
    Djurhuus, Jens Christian
    JOURNAL OF PEDIATRIC UROLOGY, 2022, 18 (03) : 323 - 324
  • [36] A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin
    Popat, R
    Apostolidis, A
    Kalsi, V
    Gonzales, G
    Fowler, CJ
    Dasgupta, P
    JOURNAL OF UROLOGY, 2005, 174 (03): : 984 - 989
  • [37] Botulinum Toxin A (Botox) Intradetrusor Injections in Adults With Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Literature Review Editorial Comment
    Karsenty, G.
    Denys, P.
    Amarenco, G.
    De Seze, M.
    Game, X.
    Haab, F.
    Kerdraon, J.
    Perrouin-Verbe, B.
    Ruffion, A.
    Saussine, C.
    Soler, J. M.
    Schurch, B.
    Chartier-Kastler, E.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 1802 - 1802
  • [38] Sustained Clinical Efficacy after Repeat Intradetrusor Botulinum Toxin Type A in the Treatment of Neurogenic Detrusor Overactivity
    Png, Keng Siang
    Toh, Khai-Lee
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2010, 39 (02) : 152 - 153
  • [39] Experience with Different Botulinum Toxins for the Treatment of Refractory Neurogenic Detrusor Overactivity EDITORIAL COMMENT
    Amaro, Joao Luiz
    INTERNATIONAL BRAZ J UROL, 2010, 36 (01): : 73 - 74
  • [40] Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity
    Conte, A.
    Giannantoni, A.
    Proietti, S.
    Giovannozzi, S.
    Fabbrini, G.
    Rossi, A.
    Porena, M.
    Berardelli, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (05) : 725 - 732